Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Elevated dorsal medial prefrontal cortex to lateral habenula pathway activity mediates chronic stress-induced depressive and anxiety-like behaviors
    Published on 2024-03-12
    1 year ago
  • Clinical decision support for bipolar depression using large language models
    Published on 2024-03-12
    1 year ago
  • Reply to Karadag: does steroid increase LPS-induced sickness behaviors?
    Published on 2024-03-12
    1 year ago
  • Critical review and recommendations for enhancement of the article on novel neurosteroid therapeutics for postpartum depression
    Published on 2024-03-11
    1 year ago
  • Late-adolescent onset of prefrontal endocannabinoid control of hippocampal and amygdalar inputs and its impact on trace-fear conditioning behavior
    Published on 2024-03-10
    1 year ago
  • Effect of serum concentrations of IL-6 and TNF-α on brain structure in anorexia nervosa: a combined cross-sectional and longitudinal study
    Published on 2024-03-08
    1 year ago
  • Reactivation of encoding ensembles in the prelimbic cortex supports temporal associations
    Published on 2024-03-06
    1 year ago
« Previous 1 … 46 47 48 49 50 … 143 Next »
Journal of Psychopharmacology
  • Belief changes associated with psychedelic use
    Published on 2022-11-01
    3 years ago
  • Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes
    Published on 2022-10-31
    3 years ago
  • The influence of stimulus onset asynchrony, task order, sex and hormonal contraception on prepulse inhibition and prepulse facilitation: Methodological considerations for drug and imaging research
    Published on 2022-10-21
    3 years ago
  • Clinical correlates of early onset antipsychotic treatment resistance
    Published on 2022-10-21
    3 years ago
  • Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia
    Published on 2022-10-21
    3 years ago
  • Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review
    Published on 2022-10-20
    3 years ago
  • D2-like receptor activation by intranasal dopamine attenuates fear responses induced by electrical stimulation of the dorsal periaqueductal grey matter, but fails to reduce aversion to pit vipers and T-maze performance
    Published on 2022-10-14
    3 years ago
« Previous 1 … 46 47 48 49 50 … 124 Next »
European Neuropsychopharmacology
  • Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression
    Published on 2023-03-01
    2 years ago
  • FDG/Raclopride-PET neuroimaging in work-related stress – A systematic review
    Published on 2023-02-28
    2 years ago
  • Silexan for treatment of anxiety and depression in the context of COVID-19
    Published on 2023-02-24
    2 years ago
  • Defining cannabis risky use: Building the plane while you fly it
    Published on 2023-02-18
    2 years ago
  • Premise, promise and challenges of MDMA assisted therapy for PTSD
    Published on 2023-02-16
    2 years ago
  • Robotics in psychiatry – Fiction or reality?
    Published on 2023-02-16
    2 years ago
  • Improving drug development in precision psychiatry by ameliorating cognitive biases
    Published on 2023-02-15
    2 years ago
« Previous 1 … 46 47 48 49 50 … 145 Next »

   Pharma Pub